Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements 2024-12-19 21:30
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete 2024-12-19 17:02
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection 2024-12-19 01:00
Neurizon Files IND Application to Support HEALEY ALS Platform Trial 2024-12-18 10:59
Amai Proteins succesfully completed world's first human clinical trial on effects of sweet proteins, with sweelin® 2024-12-17 09:00
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg 2024-12-16 22:08
World's 1st Stem Cell Book on Animals, Reveals How to Extend the Lives of Pets 2024-12-16 22:00
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea 2024-12-16 10:30
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China 2024-12-16 07:55
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024 2024-12-13 10:35
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer 2024-12-12 18:07
CBC Group R-Bridge Healthcare Fund Announces up to US$50 Million Financing for Human Investments Ltd. to Fund Motiva® Market Expansion 2024-12-12 14:14
Everest Medicines Announces the First Prescription of VELSIPITY® Issued in Macau, Officially Beginning to Benefit Asian Patients 2024-12-12 11:48
Viva Biotech Officially Establishes Boston Branch, Marking Another Milestone in Global Expansion 2024-12-11 14:44
Call for Application for 2025 Tsinghua Amgen Scholars Program 2024-12-11 14:33
2024 PHBS-CJBS Global Pitch Competition Grand Final Held 2024-12-11 12:29
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report 2024-12-10 21:27
Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL 2024-12-10 20:48
Antengene Presents Results from Two Late-Stage Clinical Studies of Selinexor at ASH 2024 2024-12-10 08:30
1 31 32 33 34 35 264